Kenvue Inc. (NYSE:KVUE) Short Interest Down 8.6% in January

Kenvue Inc. (NYSE:KVUE) saw a significant decline in short interest in January. As of January 15th, there was short interest totalling 35,720,000 shares, a decline of 8.6% from the December 31st total of 39,060,000 shares. Approximately 1.9% of the company’s stock are sold short. Based on an average trading volume of 13,550,000 shares, the short-interest ratio is currently 2.6 days.

Kenvue Stock Down 0.3 %

KVUE stock traded down $0.07 during midday trading on Monday, hitting $21.22. The company’s stock had a trading volume of 9,693,558 shares, compared to its average volume of 11,666,448. The company has a market cap of $40.69 billion, a PE ratio of 38.59, a P/E/G ratio of 2.05 and a beta of 1.45. The firm’s 50-day moving average is $21.90 and its 200-day moving average is $21.92. Kenvue has a 12 month low of $17.67 and a 12 month high of $24.46. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. The company had revenue of $3.90 billion for the quarter, compared to the consensus estimate of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. Kenvue’s quarterly revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.31 earnings per share. On average, equities research analysts forecast that Kenvue will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.86%. The ex-dividend date of this dividend is Wednesday, February 12th. Kenvue’s payout ratio is 149.09%.

Analyst Ratings Changes

KVUE has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft cut Kenvue from a “buy” rating to a “hold” rating and dropped their price target for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. Royal Bank of Canada reiterated a “sector perform” rating and set a $24.00 price target on shares of Kenvue in a research report on Monday. JPMorgan Chase & Co. boosted their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. UBS Group lowered their target price on shares of Kenvue from $24.00 to $23.00 and set a “neutral” rating on the stock in a research note on Thursday, January 16th. Finally, Citigroup decreased their price target on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating on the stock in a report on Wednesday, January 15th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $23.08.

Hedge Funds Weigh In On Kenvue

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. boosted its holdings in Kenvue by 13.7% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 62,687 shares of the company’s stock valued at $1,140,000 after acquiring an additional 7,564 shares during the period. B. Riley Wealth Advisors Inc. increased its stake in Kenvue by 7.2% in the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 27,278 shares of the company’s stock worth $496,000 after buying an additional 1,838 shares during the period. Sanctuary Advisors LLC bought a new stake in Kenvue during the 2nd quarter valued at about $3,859,000. Massmutual Trust Co. FSB ADV boosted its position in Kenvue by 6.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 8,400 shares of the company’s stock valued at $194,000 after buying an additional 492 shares during the period. Finally, AMF Tjanstepension AB grew its stake in Kenvue by 187.3% in the 3rd quarter. AMF Tjanstepension AB now owns 120,477 shares of the company’s stock worth $2,787,000 after acquiring an additional 78,540 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.